They also observed that treatment with an antibody against EphA3 significantly slowed tumour development. The antibody broken tumour arteries and disrupted the stromal micro-environment, and cancer cells died because their 'life-support' was compromised. ‘In addition, we screened numerous tumours from individual biopsies – sarcomas, melanomas and also prostate, colon, breast, brain and lung cancers – and verified EphA3 expression on stromal cells and recently forming blood vessels,’ Professor Scott stated.Gold and group used useful magnetic resonance imaging showing that bilingual adults aged 60-68 years outperformed their monolingual peers in a perceptual task-switching experiment and shown reduced activation in the remaining lateral frontal cortex and cingulate cortex, an specific area regarded as involved with task switching, the authors state. An interview with Professor Lesley JonesThe research utilized a perceptual task-switching paradigm and included a complete of 110 participants, split into younger and old age ranges. All participants completed an activity whereby stimuli, comprising two possible designs was offered in the heart of the screen. The individuals were asked to choose which color or form the stimuli were, and were necessary to alternate between color and form decisions.